Phil Skolnick, Chief Scientific Officer at OPIANT PHARMACEUTICALS, INC. (OPNT), sold 8,785 shares at $13.60 ($118K) on 2020-01-07, disclosed to the SEC on 2020-01-09.
Scheduled sale ($118k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.36 | 3,043 | $41K | 34.4% |
| 2 | $13.60 | 2,900 | $39K | 33.3% |
| 3 | $13.46 | 2,842 | $38K | 32.3% |
| Total | $13.47 avg | 8,785 | $118K | 100% |
| Filing → |
| OPNT | SELL | 2023-01-05 | $29K | — | Filing → |
| OPNT | SELL | 2022-07-15 | $7K | — | Filing → |
| OPNT | SELL | 2022-01-27 | $40K | — | Filing → |